NRSN earnings date and last-quarter result: next report 2026-09-02, last quarter miss, P/E -1.46. Updated 2026-07-23.
NeuroSense Therapeutics (NRSN) Research Hub
NeuroSense Therapeutics (NRSN) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.33 USD (-5.28%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.46, market cap 0.02B. This hub links to the full technical, earnings and options research available for NRSN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 2.33 USD (-5.28%) |
| 52-week range | 0.25 USD – 7.5 USD |
| Trend regime | Range |
| 14-day RSI | 15.5 (Oversold) |
| Trailing P/E | -1.46 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for NRSN
Covered Call on NRSN: how it works, illustrative setup around the real 2.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NRSN: how it works, illustrative setup around the real 2.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NRSN: how it works, illustrative setup around the real 2.33 USD price, max profit/loss, breakeven and when to use it. Educational.
NRSN technical analysis: range, last 2.33 USD, RSI 15.5, 52w range 0.25 USD–7.5 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NRSN in?
NeuroSense Therapeutics (NRSN) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.
Is NRSN in an uptrend or downtrend?
As of 2026-10-26, NRSN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NRSN's trailing P/E ratio?
NRSN's trailing P/E is -1.46, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does NRSN next report earnings?
NRSN is next scheduled to report earnings on 2026-09-02.